Objective: To determine the pregnancy rates of microtubal reanastomosis (MTR) and any associated clinical variables, to determine pregnancy rates and live birth rates of MTR as compared to in vitro fertilization (IVF) and to study the rates of ectopic pregnancy and spontaneous abortion (SAB) after MTR.
Study Design: Retrospective chart review.
Results: At our institution, the pregnancy rate in the first 12 months following MTR was 44.3%. The study also showed that 2 clinical variables of the MTR procedure that had higher pregnancy rates were when Hulka clips (Hulka-Clemens, Richard Wolf, Rosemont, Illinois) or Filshie clips (Coopersurgical, Lake Forest, California) were used as the mechanism of tubal occlusion and if bilateral MTR was performed instead of unilateral. There was not a significant difference in the pregnancy rates of MTR (44.3%) vs. IVF (38%). However, there was a statistically significant difference in the live birth rate of MTR (19%) vs. IVF (31%) (p=0.007). The rates of ectopic pregnancy and SAB after MTR were 10% and 15.7%, respectively.
Conclusion: This study showed a significantly higher live birth rate when patients underwent IVF as compared to MTR in the first 12 months following an MTR procedure.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
The impact of spillover and crossover effects of job stressors on pregnancy rates in couples undergoing in vitro fertilization treatments.
J Assist Reprod Genet
January 2025
Meir Medical Center, Kfar Saba, Israel.
Purpose: Studies have shown mixed findings regarding the impact of stress on the success of fertility treatments. To the best of our knowledge, stress in the context of the workplace has not been investigated to date in relation to the success of fertility treatments. This research investigates the impact of work-related stress and emotional exhaustion experienced by both partners on in vitro fertilization (IVF) treatment outcomes.
View Article and Find Full Text PDFUtilisation patterns of immunomodulators and pregnancy outcomes in systemic lupus erythematosus: Insights from Korean national data.
Lupus
January 2025
College of Pharmacy, Chung-Ang University, Seoul, South Korea.
Objectives: To investigate the trends in immunomodulator use and pregnancy outcomes among pregnant women with systemic lupus erythematosus (SLE), a condition requiring medication to maintain disease activity.
Methods: This descriptive study used data from the National Health Information Database in Korea from 2002 to 2018. We included 5,044 pregnancies initiated between 2005 and 2017 in 3,120 SLE patients.
Inter-pregnancy interval and associated factors among parous women in neighboring low-land ecologies of arsi & east shoa zone, southeast Ethiopia: a community-based cross-sectional study.
Contracept Reprod Med
January 2025
Department of Health Sciences, Global Health Unit, University Medical Center Groningen, Groningen, The Netherlands.
Background: The World Health Organization (WHO) recommends an interval of at least 24 months from the date of a live birth to the conception of the next pregnancy in order to reduce the risk of adverse maternal, perinatal, and infant outcomes. There is limited data about the implementation of this recommendation and its contributing factors in low-land ecologies in Oromia, which is the biggest regional state in Ethiopia.
Objective: To assess the inter-pregnancy interval and determine associated factors among parous women in selected low-land districts of Arsi and East Shoa Zone.
Using routine data to examine factors associated with stillbirth in three tertiary maternity facilities in Kabul, Afghanistan.
Reprod Health
January 2025
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Background: Over one-third of the global stillbirth burden occurs in countries affected by conflict or a humanitarian crisis, including Afghanistan. Stillbirth rates in Afghanistan remained high in 2021 at over 26 per 1000 births. Stillbirths have devastating physical, psycho-social and economic impacts on women, families and healthcare providers.
View Article and Find Full Text PDFIs it possible for parents to endure a stillbirth? Initial experiences, perceptions and strategies: individual in-depth interviews in Sweden 2021-2023.
BMC Pregnancy Childbirth
January 2025
Department of Women's and Children's Health, Uppsala University, Uppsala, 751 85, Sweden.
Background: Stillbirth occurs at a rate of 3.0 per thousand in Sweden. However, few studies have focused on the initial experiences of parents facing a stillbirth.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!